BPC-157-treated tendons show improved collagen organization and biomechanical strength at these timepoints in animal models
Even if prices do decrease, the cost of oral forms of these drugs is still expected to be unaffordable for the average consumer even in many high-income countries
JAMA: The Journal Of The American Medical Association 1994, 272: 1335-1340
Diabetes Care Borchardt RT, Jeffrey A, Siahaan TJ, et al
The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jrgensen has agreed to appear at a Senate hearing next week to defend the pricing of the group's semaglutide-based therapies
First in moments, then in hours, then as a baseline you can trust